Viatris - a new kind of healthcare company

Product Updates

Viatris - a new kind of healthcare company


Viatris commercialises this innovative, qualitative, precise, and rapid self-testing tool (10 minutes) available to the entire population without the need for a prescription: COVID-19 NEUTRALISING IgG SEROLOGICAL SELF-TEST.
The self-test is carried out from a blood sample and must be done at least 14 days after completing the vaccination cycle.
The self-test has shown to measure a seroconversion rate of 98.3 per cent for the Pfizer vaccine, 98.5 per cent for the AstraZeneca vaccine and 95.2 per cent for the Moderna vaccine.
Email vinesh.vaghela@viatris.com for sales enquires.

Record my learning outcomes

Product Updates

Share: